| Date | Title | Description |
| 27.08.2025 | Plug and Play to Host Inaugural Community Series Event in Cambodia to Strengthen Local Startup Ecosystem | PHNOM PENH, Cambodia, Aug. 27, 2025 /PRNewswire/ -- Plug and Play Cambodia, in partnership with the Ministry of Post and Telecommunications (MPTC) and AUPP Technology Center (ATC), will be hosting its inaugural Community Series: Scale and C... |
| 22.07.2025 | Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific | SINGAPORE, July 22, 2025 /PRNewswire/ -- The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass of innovative therapies that will redefine treatment, attract investment and improve lives, a new e... |
| 25.06.2025 | Plug and Play Launches Taiwan Office and Opens Applications for Inaugural Accelerator | TAOYUAN, June 25, 2025 /PRNewswire/ -- Plug and Play, the world's largest innovation platform, has officially opened its first office in Taoyuan City. This expansion marks a major milestone in the company's mission to connect startups with ... |
| 28.05.2025 | Plug and Play Expands to Cambodia in Partnership with Ministry of Post and Telecommunication (MPTC) and AUPP Technology Center (ATC) | SINGAPORE, May 28, 2025 /PRNewswire/ -- The Cambodian Ministry of Post and Telecommunications (MPTC) is a founding anchor partner for open innovation platform Plug and Play's new location in Phnom Penh, with the American University of Phnom... |
| 31.03.2025 | The Rise of European Startups: A Tale of Investment and Transformation | In the heart of Europe, a new wave of entrepreneurship is rising. Cities like Madrid and Berlin are transforming, fueled by fresh investments and innovative ideas. The winds of change are blowing, and they carry the scent of opportunity.
Re... |
| 28.03.2025 | EA Ventures has announced a new €20M fund in partnership with Plug and Play | EA Ventures, the venture capital arm of Kazakhstan’s EA Group Holding, has announced a new €20M fund in partnership with Plug and Play.
The fund, based in Madrid, aims to provide backing to early-stage startups across Europe, with a particu... |
| 23.12.2024 | Sheffield United takeover completed by COH Sports | Sheffield United have been taken over by COH Sports, the Championship club said on Monday, after the American consortium completed a buyout from Saudi Arabia's United World Group.
COH Sports is led by Steven Rosen, founder and chairman of R... |
| 04.12.2024 | The Housing Dilemma: Baby Boomers Face a Crisis of Accessibility | The American landscape is shifting. Baby boomers, once the proud owners of homes that skyrocketed in value, now find themselves at a crossroads. As they approach their golden years, many are grappling with a harsh reality: accessible housin... |
| 03.12.2024 | Jimini Health: $8 Million Secured For Transforming Mental Health Therapy | Jimini Health – a digital health company setting a new standard in mental healthcare with its clinician-led therapy model augmented by responsible AI – announced its launch with $8 million in pre-seed funding, including from Zetta Venture P... |
| 11.10.2024 | Cybersecurity Champions: Bay Area Leaders Shine at ORBIE Awards | In the heart of Silicon Valley, where innovation meets vulnerability, the BayAreaCISO ORBIE Awards celebrated the unsung heroes of cybersecurity. On October 10, 2024, the San Jose Marriott buzzed with energy as executives from top tech firm... |
| 10.10.2024 | Winners of 2024 BayAreaCISO ORBIE Awards Announced By BayAreaCISO | Executives from Intel, Equinix, Genesys, Blue Shield of California, Chime, Guardant Health & Flock Safety Recognized for their Achievements.
SAN JOSE, Calif., Oct. 10, 2024 /PRNewswire-PRWeb/ -- BayAreaCISO announced the winners of its ... |
| 30.08.2024 | Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGF... | Guardant360® CDx is the first blood-based companion diagnostic to be approved in Japan for the detection of EGFR exon 20 insertion mutations
TOKYO, Aug. 30, 2024 /PRNewswire/ -- Guardant Health Japan Corp. (HQ: Minato-ku, Tokyo/ Representat... |
| 25.07.2024 | ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally | SINGAPORE, July 25, 2024 /PRNewswire/ -- ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests acro... |
| 24.05.2024 | New Blood Test for Colon Cancer Early Detection Gets FDA Panel Nod | By Quincy Jon
Published May 24, 2024 3:55PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
A Food and Drug Administration (FDA) advisory group recommended the approval of a novel ... |
| 29.04.2024 | Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors | BOSTON, April 29, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent di... |
| 25.03.2024 | Health | Researchers unveil new blood test that detects colon cancer | Elise Takahama | (TNS) The Seattle Times
Researchers at the Fred Hutchinson Cancer Center have unveiled a new type of blood test used to detect colorectal cancer, with high hopes not only in its ability to reduce barriers to testing for thi... |
| 08.01.2024 | Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa | PALO ALTO, Calif., Jan. 8, 2024 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Hikma Pharmaceuticals PLC ("Hikma"), a multinational pharmaceutical company, today announced an agreemen... |
| 13.11.2023 | Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea | SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medi... |
| 15.02.2023 | Guardant Health Initiates New Study to Examine the Impact of Shield Blood Test to Increase Screening Compliance for Colorectal Cancer | Shield blood test will be used to evaluate whether blood test option improves adherence to colorectal cancer screening recommendations in medically underserved populations at Federally Qualified Health Centers
Guardant Health, a leading pre... |
| 16.12.2022 | A Silicon Valley biotech just showed a simple blood test can detect a hidden and deadly type of cancer. But the results fell short of investors' hopes. | A standard blood draw. Hollis Johnson/Business Insider
Guardant Health said that its blood test to screen for cancer caught 83% of colorectal cancer cases.
Guardant says this could unlock an $20 billion market for colorectal cancer screenin... |
| 06.07.2022 | Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China | Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials
SINGAPORE, July 6, 2022 /PRNewswire/ -- Guardant Health, ... |
| 24.02.2021 | Guardant Health Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Revenue Outlook for Full Year 2021 | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb 24, 2021--
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advance... |
| 27.12.2019 | Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019 | – From Google’s acquisition of Fitbit to Philips acquisition of Carestream Health’s health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter.Q1 M&A Activity
Jo... |
| 26.09.2019 | At the sixth annual Pear Demo Day, weather balloons, branded credit cards and lots of top degrees | Pear, a Palo Alto-based seed-stage fund that has made its name through early bets on Guardant Health, DoorDash, Memebox and Gusto, hosted its sixth annual demo day this week in what proved to be a scorchingly hot afternoon in Woodside, Cali... |
| 07.06.2019 | A peek inside Sequoia Capital’s low-flying, wide-reaching scout program | Ten years ago, Sequoia Capital began quietly encouraging founders of its portfolio companies to consider which of their founder friends they might like to get behind financially. Sequoia would let them write checks to those companies, and i... |
| 30.05.2019 | Third Rock unveils liquid biopsy biotech, leading $110M bet it can Thrive in early cancer detection | Cancer is the second leading cause of death globally — the earlier it is detected, the better shot patients have of bouncing back. Researchers have long pursued a minimally-invasive, effective test to expose early mar... |
| 06.04.2019 | March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary | A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Ha... |
| 26.03.2019 | A new lawsuit involving Stanford and Sequoia Capital highlights fights to come over cell-free DNA testing | This morning, a publicly traded transplant diagnostics company called CareDx, along with Stanford University, sued another publicly traded genetic testing company, Natera, for patent infringement.
Much appears to be at stake, and it all cen... |
| 01.11.2018 | Pricey precision medicine often financially toxic for cancer patients | When Kristen Kilmer was diagnosed with incurable breast cancer at age 38, her first thought was of her 8-year-old daughter. Kilmer lost her own mother as a teenager and was determined to get more time with her only child.
Kilmer searched fo... |
| 28.10.2018 | These 14 startups, endorsed by the seed-stage investment firm Pear, just hit the fundraising trail | Earlier this week, in a beautiful garden in Woodside, Calif., the team at the five-year-old seed-stage venture firm Pear hosted its fifth annual demo day. It’s an event that’s limited to roughly 100 VCs who year after year happily fill the ... |
| 06.09.2018 | Liquid biopsy firm Guardant Health files for $100M IPO | A spokesperson for Guardant declined to comment.
The IPO filing follows a series of large venture capital raises that the company has made over the past couple of years. Last May, it secured $360 million in a Series E funding round from a s... |
| 12.01.2018 | Digital health investments reached record level in 2017 | Technology companies focused on the patient/consumer experience once again was the dominant category with 191 deals, according to StartUp Health.
Rock Health noted that 60 percent of the companies funded last year sell to providers.
Photo: ... |
| 01.08.2017 | Чтобы приблизить будущее, SoftBank должен быть повсюду | Самоуправляемые автобусы, роботы, спутники, биотехнологии — в какие ИТ-проекты вкладывает средства японский конгломерат.
4 4 комментария
2728 просмотров
Масаёси Сон, основатель и генеральный директор компании SoftBank
Компанию по оптовой пр... |
| 06.07.2017 | Report: Alphabet venture arm GV, Khosla Ventures claim top spots in healthcare investment ranks | Two investors that embrace this hybrid approach to healthcare investment also topped the category for investment volume — Alphabet’s investment arm, GV, and Khosla Ventures with seven deals apiece.
GV led or took part in healthcare investme... |
| 12.05.2017 | Guardant Health adds $360 million to its war chest | Guardant Health, a four-year-old, Redwood City, Ca.-based biotech company that sells blood tests to track and potentially detect cancer, has raised a whopping $360 million from investors, bringing its total funding to $550 million. SoftBank... |
| 12.05.2017 | SoftBank leads $360m funding in cancer screening firm Guardant Health | Premium
US-based Guardant Health has raised $360 million in a financing round led by Japanese investment giant SoftBank.
Continue reading this story with a subscription to DealStreetAsia.
Subscribe
Already a subscriber? Log in
Contact us fo... |
| 11.05.2017 | Guardant Health Raises $360M |
REDWOOD CITY, CA, Guardant Health, a startup that wants to make cancer testing as simple as taking a blood test, just raised $360 million today.
>> Click here for more funding data on Guardant Health
>> To export Guardant He... |
| 11.05.2017 | Cancer screening firm Guardant Health raises $360 million to sequence tumor DNA of 1 million patients | Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan round of funding led by a subsidiary of Japanese telecoms giant SoftBank, with participation from Sequoi... |
| 11.05.2017 | Guardant Health Secures $360m in Funding | Guardant Health, a Redwood City, Calif.-based developer of comprehensive liquid biopsies, secured $360m in new funding.
The round, which brought total funding to more than $500m, was led by a SoftBank Group subsidiary with participation fro... |
| 11.05.2017 | Guardant Health Raises $360M in Race to Create Cancer Blood Tests | - |
| 11.05.2017 | Cancer screening firm Guardant Health raises $360 million to sequence tumor DNA of 1 million patients | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan... |
| 11.05.2017 | Term Sheet — Thursday, May 11 | “A FUN YEAR”
M&A: Paddy Power Betfair has acquired Draft, a daily fantasy sports startups for $48 million including incentives. This deal, while small, is significant for two reasons: One, it’s validation for a market full of question m... |
| 12.04.2017 | A look at who was spending, on what, in the first quarter | This morning, the research firm CB Insights, in partnership with the services firm PwC, released a report on the state of VC in the first quarter of this year. It does a great job of breaking down what’s what, so we’re basically just cuttin... |
| 30.03.2017 | CRV just put advanced bioengineering on its shopping list | CRV, an early-stage venture firm that made headlines last year for its stance on then-candidate Donald Trump’s campaign, is looking to get out a new (non-political) message: It’s diving more deeply into the business of AI-driven biotech.
Th... |
| 22.07.2016 | N-of-One’s new funding will expand precision medicine clinical decision support in China, Europe | Cournoyer said the Lexington, Massachusetts company has raised $14 million to date. Some of the angel investors that backed N-of-One’s $7 million series A round returned for the series B, in which it secured institutional investment from Pr... |
| 04.06.2016 | A Blood Test for Cancer Gets Closer | A blood test is one of the least invasive ways for doctors to get a peek inside the body. But when it comes to cancer, blood isn’t exactly a reliable source of information. While tumors do shed fragments into the blood, they’re rare and har... |
| 15.03.2016 | Video: Guardant Health CEO Helmy Eltoukhy at Splash Health | Tackling cancer with technology
At Vator Splash Health 2016, Helmy Eltoukhy, Founder & CEO of Guardant Health, sat down with Bambi Francisco to tackle cancer with technology.
Thanks to our main sponsors KPMG, Javelin Venture Partners, S... |
| 23.02.2016 | $1,000 is the "right price" for human genome | Guardant Health CEO Helmy Eltoukhy kicks of Splash in a fireside chat with Bambi Francisco
Bambi Francisco, CEO and founder of Vator, kicked off Vator Splash Health 2016 this morning in a fireside chat with Helmy Eltoukhy (Founder & CEO... |
| 14.01.2016 | Transcript: Alfred Lin at Post Seed 2015 | Early-stage strategy talks with Bambi Francisco of Vator
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Alfred Lin, Partner of Sequoia Capital, sat down with Bambi Francisco (Vator) over a Fireside Chat.
Fireside chat w... |
| 10.01.2016 | The competition: Who is Illumina’s new $100M startup, Grail, up against in cancer liquid biopsy screening? | But other companies have been touting advances in liquid biopsy screening for some time now. This is hardly the first gander at a pan-cancer test, right? San Diego-based Pathway Genomics, for instance, announced this past summer that it had... |
| 08.01.2016 | Guardant Health Nabs $100M for Biopsy-Free Cancer Genomic Testing | Guardant Health, a Redwood City, CA-based company revolutionizing cancer detection through biopsy-free tumor sequencing has raised $100M in Series D funding led by healthcare-investment firm OrbiMed. Existing Guardant Health investors Khosl... |
| 07.01.2016 | Guardant Health announced an almost $100M Series D round for its cancer blood test | According to Xconomy, the new funding will be directed toward greater adoption among the roughly 10,000 oncologists in the U.S., 2,000 of which have already ordered the company’s tests.
“There are a lot who don’t use it with everyday care p... |
| 07.01.2016 | Guardant Health, Which Tests for Cancer Through Blood Samples, Raises $100M In Series D Funding | Guardant Health, a three-year-old, Redwood Shores, Ca.-based company whose non-invasive genomic sequencing test for cancer requires just two vials of blood, has raised nearly $100 million in Series D funding roughly one year after closing o... |
| 07.01.2016 | Guardant Health raises nearly $100M for cancer detection | VCs pile into technology to make cancer monitoring less invasive and reasonably priced
Guardant Health, a fast-growing startup that wants to make cancer detection a part of an annual check-up, just announced it's raised nearly $100 million ... |
| 07.01.2016 | Guardant Health Completes First Close on Majority of $100M Series D Round | Guardant Health, a Redwood City, CA-based developer of non-invasive cancer genomic sequencing test, completed a first closing on the majority of a $100m Series D round.
The financing round, which adds to the nearly $100 million already rais... |
| 07.01.2016 | Daily funding roundup - January 7, 2016 | Guardant Health raised $100M; Founders Fund invested $52M in NuBank; Sisense received $50M funding
IQuity Labs, a Nashville, TN-basedbiotechnology company specializing in diagnostic tests for autoimmune disease and related conditions, secur... |
| 07.01.2016 | Guardant Health Pulls In $100M Series D Round |
REDWOOD CITY, CA, Guardant Health today announced it has completed a first closing on the majority of a $100 million Series D capital raise, which includes equity financing and a term loan facility.
>> Click here for more funding d... |
| 06.01.2016 | Transcript: Vinod Khosla at Post Seed 2015 | Silicon Valley investor talks VC strategies with Semil Shah of Haystack
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Vinod Khosla, Founder of Khosla Ventures, sat down with Bambi Francisco (Vator) over a Fireside Chat... |
| 05.01.2016 | Transcript: John Doerr at Post Seed 2015 | Legendary Silicon Valley VC talks early-stage VC strategy with Paul Martino of Bullpen Capital
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, John Doerr, General Partner of Kleiner Perkins, sat down with Paul Martino (B... |
| 22.12.2015 | Vator Splash LA 2015 Finalist - 8/omakase | Check out Michael Won's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort 8/Omakase Founder and CEO, Michael Won, presented live on stage.
In fashion, small innovations have led to a platform for big things. 8... |
| 21.12.2015 | Vator Splash LA 2015 Finalist - Authorea | Check out Alberto Pepe Gentile's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort Authorea is the collaborative platform to write, share, and discuss research. It was created in 2013 by a Harvard astrophysici... |
| 18.12.2015 | Vator Splash LA 2015 Winner - Healthiest | Check out Crystal Brown's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort Healthiest Inc., took home the gold. Here's the video of Crystal Brown, Healthiest Inc. Founder and CEO, giving the winning presentat... |
| 17.12.2015 | Vator Splash LA 2015 People's Choice Award Winner - Kanga | Check out Everett Steele's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort Kanga Technology, won the People's Choice Award. Here's the video of Everett Steele, Kanga Technology Founder and CEO, giving the wi... |
| 17.12.2015 | Video: Post Seed CEOs share fundraising stories | Founders from Filament, Homelight, Namely, Classy and Scripted at Post Seed 2015
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Cory Johnson, Editor-at-large at Bloomberg, moderated the panel "Post-Seed CEOs".... |
| 16.12.2015 | Vator Splash LA 2015 Winner - Kangarootime | Check out Scott Wayman's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort Kangarootime, took home the gold. Here's the video of Scott Wayman, Kangarootime Founder and CEO, giving the winning presentation.
Kan... |
| 15.12.2015 | Video: What Unicorns looked like at Series A/ Post-Seed | At Post Seed 2015, VCs from Javelin, Lowercase, Shasta, IVP and Intel share insight
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Alex Konrad, Staff Writer at Forbes moderated the panel "What Unicorns looked like ... |
| 15.12.2015 | Vator Splash LA 2015 Finalist - Staffly | Check out Bjorn Ovick's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort Staffly, a startup that instantly connects retailers with screened, insured, and trained Staffly™ Staffers through their mobile devices... |
| 14.12.2015 | Vator Splash LA 2015 Finalist - Smart Plate | Check out Anthony Ortiz's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort SmartPlate (Fitly) is the world’s first connected plate that instantly analyzes everything people eat with up to 99% accuracy while i... |
| 14.12.2015 | Video: Vinod Khosla and Bambi Francisco at Post Seed 2015 | Khosla Ventures' Founder shares early-stage strategies at Bullpen, Vator, Venture51's VC even
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Vinod Khosla, Founder of Khosla Ventures, sat down with Bambi Francisco (Vator... |
| 11.12.2015 | Sweep - Vator Splash LA Class of 2015 | Check out Jackson Gates's presentation on stage and the judges' feedback
Vator Splash LA Class 2015 cohort Sweep is a new mobile finance app that helps you get ahead of bills, expenses and savings goals so you never have to budget again. Un... |
| 11.12.2015 | Video: Alfred Lin and Bambi Francisco at Post Seed 2015 | Sequoia Capital's Lin talks early-stage strategy at Bullpen, Vator and Venture51's annual VC event
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Alfred Lin, Partner of Sequoia Capital, sat down with Bambi Francisco (Va... |
| 10.12.2015 | Video: John Doerr and Paul Martino at Post Seed 2015 | Kleiner Perkins' Doerr talks VC strategy, unicorns at Bullpen, Vator, Venture51's annual VC event
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, John Doerr, General Partner of Kleiner Perkins, sat down with Paul Martino... |
| 10.12.2015 | TubeMogul's Brett Wilson on the trouble with walled gardens | Founder & CEO gives keynote at TubeMogul University Tahoe 2015
In response to the misaligned practices of so many other companies in the video advertising industry, TubeMogul CEO Brett Wilson delivered both this keynote at his company's... |
| 09.12.2015 | Video: Scott Kupor & Semil Shah at Post Seed 2015 | Andreessen Horowitz's Kupor talks early-stage venture at Bullpen, Vator, and Venture51's VC event
At Post Seed 2015, hosted by Bullpen Capital, Vator and Venture 51, Scott Kupor (Andreessen Horowitz) sat down with Semil Shah (Haystack) over... |
| 22.09.2015 | Cancer treatment is on the brink of a data revolution | Science Cancer treatment is on the brink of a data revolution
Lydia Ramsey Pflanzer
2015-09-22T20:29:14Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It indicates the ability ... |
| 03.09.2015 | Seven New Startups From Silicon Valley’s Favorite New Demo Day | For the second time in its two-year history, in a small space that’s easy to miss on a leafy Palo Alto street, the boutique venture firm Pejman Mar brought together seven startups yesterday to present their fledgling ideas to some of the be... |
| 19.08.2015 | Guardant Health And Flatiron Health Team Up To Cure Cancer With Big Data | Every year, 8 million people around the world die from cancer, and 14 million people find out they have the disease. Guardant Health and Flatiron Health are joining forces in an aim to cut those numbers down using big data and analytics.
Th... |
| 06.02.2015 | Funding roundup - week ending 2/06/15 | AnyPerk, Pley, Guardant, HomeLight, SketchDeck, DesignCrowd, Taboola, Qumulo, BucketFeet, Skimlinks
Seed stage
SketchDeck, a full graphic design on demand service, raised $500,000 from Y Combinator, Dharmesh Shah, Michael Siebel and other a... |
| 03.02.2015 | Guardant Health takes another $50M for ‘liquid biopsy’ cancer test | Health care is just now starting to effectively use information from the human genome to diagnose and treat disease. Nowhere is this more crucial than in the treatment of cancer, from which 7.6 million people in the U.S. die each year, and ... |
| 03.02.2015 | Guardant Health Secures Additional $50M |
REDWOOD CITY, CA, Guardant Health today announced the completion of its Series C financing for approximately $50 million.
>> Click here for more funding data on Guardant Health
>> To export Guardant Health funding data to PD... |
| 03.02.2015 | Guardant Health Secures $50 Million In Series C To Help More Doctors Track Cancer In Real Time | Guardant Health announced today that it has raised $50 million in Series C funding for its biopsy-free blood cancer screening test Guardant360. This puts the total funding for the medical technology startup at $90 million. Lightspeed Ventur... |
| 03.02.2015 | Cancer-tracking Guardant lands $50M from Lightspeed | Genomic sequencing technology helps Guardant Health improve treatment decisions
In the last three years, two of my relatives died of cancer. While I was not very close to either situation, I was part of the string of emails, explaining to f... |
| 03.02.2015 | Guardant Health takes another $50M for ‘liquid biopsy’ cancer test | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Health care is just now starting to effectively u... |
| 03.02.2015 | Guardant Health Completes $50M Series C Financing | Guardant Health, a Redwood City, Calif.-based developer of diagnostic technologies, completed its $50m Series C financing.
The funding was led by Lightspeed Venture Partners with participation from Formation 8 and existing investors Khosla ... |
| 23.04.2014 | Guardant Health raises $30M for its revolutionary cancer detection tech | Health tech startup Guardant Health has raised a fresh $30 million round of funding.
The startup is focused on developing a non-invasive cancer screening tool called Guardant 360 that uses blood samples instead of tissue, as VentureBeat pre... |
| 23.04.2014 | Guardant Health raises $30M for its revolutionary cancer detection tech | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Health tech startup Guardant Health has raised a ... |
| 22.04.2014 | Guardant Health Completes $30M Series B Financing | Guardant Health, a Redwood City, CA-based developer of cancer diagnostic technologies, completed an over $30m Series B financing.
The round was led by Khosla Ventures with participation from existing investor Sequoia Capital and new investo... |
| 22.04.2014 | Guardant Health Announces $30M in Series B |
REDWOOD CITY, CA, Guardant Health today announced the completion of its Series B financing for over $30 million.
>> Click here for more funding data on Guardant Health
>> To export Guardant Health funding data to PDF and Exc... |
| 15.02.2014 | If it works, Guardant’s new approach to detecting cancer may save your life | A startup has developed new technology that it claims can open a new front in the war on cancer.
Guardant Health has developed a non-invasive screening tool that relies on a blood sample rather than tissue. The test, dubbed the “Guardant 36... |
| 11.02.2014 | Guardant Health Raises $10M |
REDWOOD CITY, CA, Startup developing a blood test for cancer announced it raised $10 million from Sequoia Capital.
>> Click here for more funding data on Guardant Health
>> To export Guardant Health funding data to PDF and E... |
| 11.02.2014 | Sequoia-Backed Guardant Health Wants To Improve Cancer Treatment And Diagnosis Via A New Blood Test | When testing for the possibility of certain types of cancer, doctors often do surgery to retrieve biopsies for genetic analysis. But when a patient has already had cancer, and is testing for a possibility of recurrence, Helmy Eltoukhy, the ... |
| - | Digital health investments reached record level in 2017 | Although their figures differ, StartUp Health and Rock Health both noted in their end-of-year digital health reports that dealflow reached a new peak in 2017. StartUp Health counted $11.5 billion on the back of 794 deals, partly because it ... |
| - | N-of-One’s new funding will expand precision medicine clinical decision support in China, Europe | Christine Cournoyer, N-of-One CEO
More than three years after the launch of its molecular diagnostics clinical decision support business, much has changed at N-of-One. The company has expanded its hospital customer base, from hospitals taki... |
| - | Guardant Health announced an almost $100M Series D round for its cancer blood test | Guardant Health, a Redwood City, Calif.-based company, has raised nearly $100 million in Series D financing led by OrbiMed Advisors. The company has created a non-invasive genomic sequencing blood test for cancer.
With only two vials of blo... |
| - | Investor insights: Ling Wong of Sea Lane Ventures and Lightspeed Venture Partners | Investors and healthcare startups are center stage at the annual INVEST conference in Chicago March 28-30, 2022. In the runup to the conference, we’re doing a series of interviews with investors on their approach to startups across the four... |
| - | Liquid biopsy firm Guardant Health files for $100M IPO | Guardant Health, a liquid biopsy diagnostics company that has already raised more than $500 million in venture capital funding, is looking to make its stock market debut.
In an S-1 filing with the Securities and Exchange Commission, the Red... |
| - | The competition: Who is Illumina’s new $100M startup, Grail, up against in cancer liquid biopsy screening? | On the eve of this year’s J.P. Morgan Healthcare Conference, Illumina made a much-hyped announcement: With $100 million in Series A funding, it just launched Grail, a diagnostics startup that is developing a pan-cancer blood test. The circu... |
| - | Report: Alphabet venture arm GV, Khosla Ventures claim top spots in healthcare investment ranks | Healthcare investments hit $3.8 billion in the second quarter of 2017, marking a spike in these deals and a milestone for the healthcare industry in general, according to StartUp Health’s half year report. The trend of fewer deals but with ... |
| - | Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar 2, 2021--
Guardant Health, Inc. (Nasdaq: GH) has CE-marked Guardant360 ® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any solid malignant ... |
| - | At Biomed Israel conference, medical start-ups discuss challenges in reaching success
Into the Land: The Forgery Scandal | The worldwide economic downturn and Israel’s internal political turmoil have investors sitting on the fence about funding local tech companies. However, that did not prevent thousands of industry leaders from 45 countries from attending the... |
